腹膜透析动物模型为人类改善腹膜透析治疗提供了重要的参考和依据，虽然到人类临床应用之前，仍需进行更多的研究和验证。目前研究者们已经使用小鼠、大鼠、兔子、猪等动物建立了腹膜透析动物模型。从新型透析液的研发，到腹膜炎、腹膜纤维化等并发症的治疗和机制研究，腹膜透析动物模型都发挥了重要的价值。
Peritoneal dialysis (PD) related animal models provide important references for improving PD treatment in humans, despite the fact that animal results have to be further studied before they can be used clinically. Currently, PD related models have been established in mice, rats, rabbits, pigs and other animals. These animal models offer valuable information about the mechanisms of PD complications such as peritonitis and peritoneal fibrosis, and also about the development of new dialysates.
[1]van Gelder MK,de Vries JC,Simonis F,et al.Evaluation of a system for sorbent-assisted peritoneal dialysis in a uremic pig model[J].Physiol Rep.2020 Dec;8(23):e14593. doi: 10.14814/phy2.14593.PMID: 33278069; PMCID: PMC7718839.
[2]Jovanovi? N,Zuni?-Bozinovski S,Trpinac D,et al.Ultrastructural changes of the peritoneum in a rabbit model of peritoneal dialysis[J]. Vojnosanit Pregl.2013 Nov;70(11):1023-8. doi: 10.2298/vsp1311023j. PMID: 24397197.
[3]王羽，康瀚，钟晓红，等.慢性肾衰竭SD大鼠腹膜透析模型的建立与应用[J].动物医学进展，2020，41(09)：55-60.
[4]Garosi G,Di Paolo N.The rabbit model in evaluating the biocompatibility in peritoneal dialysis[J].Nephrol Dial Transplant. 2001 Mar;16(3):664-5. doi: 10.1093/ndt/16.3.664. PMID: 11239063.
[5]de Vries JC,van Gelder MK,Monninkhof AS,et al.A Uremic Pig Model for Peritoneal Dialysis[J].Toxins (Basel).2022 Sep 14;14(9):635. doi: 10.3390/toxins14090635.PMID: 36136573; PMCID: PMC9503030.
[6]González-Mateo GT,Pascual-Antón L,Sandoval P,et al.Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis[J].J Vis Exp. 2018 Jul 19;(137):56746. doi: 10.3791/56746. PMID: 30080204; PMCID: PMC6126517.
[7]周伟东，魏连波，张志锋，等.自制腹透管尿毒症大鼠腹膜透析模型的建立[J].第四军医大学学报，2008(08)：749-751.
[8]汪晓月，胡威，陈佳，等.一种改良的腹膜透析大鼠模型建立[J].中国血液净化，2019，18(04)：246-249.
[9]Pawlaczyk K,Baum E,Schwermer K,et al.Animal Models of Peritoneal Dialysis:Thirty Years of Our Own Experience[J].Biomed Res Int. 2015;2015:261813.doi: 10.1155/2015/261813.Epub 2015 Jul 6.PMID: 26236720; PMCID: PMC4506843.
[10]孙林.基于PI3K/Akt/mTOR通路探讨扶肾方抑制腹膜透析相关腹膜血管新生机制的研究[D].天津中医药大学,2021.
[11] Nakano T,Kumiko T,Mizumasa T,et al.The glucose degradation product methylglyoxal induces immature angiogenesis in patients undergoing peritoneal dialysis［J］.Biochem Biophys Res Commun,2020,525（3）:767-772.
[12]彭凯月，韩庆烽.基于艾考糊精透析液的腹膜透析治疗进展[J].中国血液净化，2022，08：595-598.
[13]Morelle J,Marechal C,Yu Z,et al.AQP1?Promoter Variant,Water Transport,and Outcomes in Peritoneal Dialysis[J].N Engl J Med.2021 Oct 21;385(17):1570-1580.doi: 10.1056/NEJMoa2034279. PMID: 34670044.
[14]Morelle J,Sow A,Fustin C-A,et al.Mechanisms of crystalloid versus colloid osmosis across the peritoneal membrane[J].J Am Soc Nephrol?2018;29:1875-1886.
[15]Zhou Q,Bajo MA,Del Peso G,et al.Preventing peritoneal membrane fibrosis in peritoneal dialysis patients[J].Kidney Int,2016,90(3):515-524．
[16]Yamada M,Hirai Y,Inoue D,et al.Increased expression of epimorphin in a peritoneal fibrosis mouse model[J].Perit Dial Int.2022 Sep;42(5):522-529.doi: 10.1177/08968608211051572. Epub 2021 Oct 12.PMID: 34641723.
[17]Yu F,Yang J,Chen J,et al.Bone Marrow Mesenchymal Stem Cell-Derived Exosomes Alleviate Peritoneal Dialysis-Associated Peritoneal Injury[J]. Stem Cells Dev.2023 Apr;32(7-8):197-211.doi: 10.1089/scd.2022.0244. Epub 2023 Feb 20.PMID: 36691747.
[18]Wu J,Li J,Feng B,et al.Activation of AMPK-PGC-1α pathway ameliorates peritoneal dialysis related peritoneal fibrosis in mice by enhancing mitochondrial biogenesis[J].Ren Fail.2022 Dec;44(1):1545-1557. doi: 10.1080/0886022X.2022.2126789. PMID: 36148521; PMCID: PMC9518249.
[19]Huang Q,Sun Y,Sun J,et al.Proteomic Characterization of Peritoneal Extracellular Vesicles in a Mouse Model of Peritoneal Fibrosis[J].J ProteomeRes.2023Mar3;22(3):908-918. doi: 10.1021/acs.jproteome.2c00713. Epub 2023 Jan 17.PMID:36648763.
[20]Kunoki S,Tatsukawa H,Sakai Y,et al.Inhibition of Transglutaminase 2 Reduces Peritoneal Injury in a Chlorhexidine-Induced Peritoneal Fibrosis Model[J].LabInvest.2023Apr;103(4):100050.doi:10.1016/j.labinv.2022.100050.Epub 2023 Jan 10.PMID: 36870292.
[21]Lee Y,Lee J,Park M,et al.Inflammatory chemokine (C-C motif) ligand 8 inhibition ameliorates peritoneal fibrosis[J].FASEB J.2023 Jan;37(1):e22632.doi: 10.1096/fj.202200784R.PMID: 36468785.
[22]王莹莹，沈瑞芬，梁耀军.腹膜透析相关性腹膜炎动物模型的构建[J].医学综述，2022，04：682-686.
[23]Fernandez JU,Millrine D,Jones SA. Tracking Competent Host Defence to Chronic Inflammation: An In Vivo Model of Peritonitis[J].Methods Mol Biol. 2018;1725:65-75.doi:10.1007/978-1-4939-7568-6_6.PMID:29322409.
[24]Zhang Y,Feng J,Wang Q,et al.PPAR-γ agonist rosiglitazone ameliorates peritoneal deterioration in peritoneal dialysis rats with LPS-induced peritonitis through up-regulation of AQP-1 and ZO-1[J]. Biosci Rep.2018 Jun 21;38(3):BSR20180009.doi: 10.1042/BSR20180009.PMID: 29871973;PMCID:PMC6013694.
[25]Witowski J,Kamhieh-Milz J,Kawka E,et al.IL-17 in Peritoneal Dialysis-Associated Inflammation and Angiogenesis:Conclusions and Perspectives[J].FrontPhysiol.2018Nov26;9:1694.doi:10.3389/fphys.2018.01694.PMID:30534087;PMCID:PMC6275317.
[26]Xu Z,Qiao S,Qian W,et al.Card9 protects fungal peritonitis through regulating Malt1-mediated activation of autophagy in macrophage[J].Int Immunopharmacol.2022 Sep;110:108941.doi: 10.1016/j.intimp.2022.108941. Epub 2022 Jul 16.PMID:35850054.
